Published in Proc Natl Acad Sci U S A on December 11, 2007
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest (2010) 3.10
A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology (2011) 2.06
Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer. Cell (2015) 1.89
Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog (2014) 1.88
Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nat Commun (2015) 1.66
Renaissance for mouse models of human hematopoiesis and immunobiology. Nat Immunol (2009) 1.54
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid. Mol Ther (2016) 1.54
Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest (2012) 1.52
The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment. Retrovirology (2011) 1.42
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia. Nat Commun (2016) 1.41
Towards a small animal model for hepatitis C. EMBO Rep (2009) 1.34
New horizons for studying human hepatotropic infections. J Clin Invest (2010) 1.16
Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. J Clin Invest (2014) 1.14
Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity. Methods Mol Biol (2010) 1.11
Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe (2015) 1.07
Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids. Mol Ther (2015) 1.03
Heme and HO-1 Inhibition of HCV, HBV, and HIV. Front Pharmacol (2012) 1.01
Hepatitis C virus infection and related liver disease: the quest for the best animal model. Front Microbiol (2013) 0.99
Liver xeno-repopulation with human hepatocytes in Fah-/-Rag2-/- mice after pharmacological immunosuppression. Am J Pathol (2010) 0.94
Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice. J Immunol (2013) 0.91
Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax. Pathog Glob Health (2015) 0.90
Evidence for a common progenitor of epithelial and mesenchymal components of the liver. Cell Death Differ (2013) 0.90
Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis. Nat Protoc (2012) 0.89
Development of humanized mouse models to study human malaria parasite infection. Future Microbiol (2012) 0.87
Hepatitis C virus experimental model systems and antiviral drug research. Virol Sin (2010) 0.87
Animal models for the study of HCV. Curr Opin Virol (2015) 0.86
In vivo models of hepatitis B and C virus infection. FEBS Lett (2016) 0.85
Mouse models for therapeutic vaccination against hepatitis B virus. Med Microbiol Immunol (2014) 0.83
Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens. Dis Model Mech (2008) 0.83
Visualizing hepatitis C virus infection in humanized mice. J Immunol Methods (2014) 0.82
Generation of functional hepatic cells from pluripotent stem cells. J Stem Cell Res Ther (2012) 0.82
Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance. Viruses (2016) 0.80
Humanized murine model for HBV and HCV using human induced pluripotent stem cells. Arch Pharm Res (2012) 0.80
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis. Nat Protoc (2015) 0.79
Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies? Cancer Lett (2013) 0.78
Molecular detection and quantification of Plasmodium falciparum-infected human hepatocytes in chimeric immune-deficient mice. Malar J (2013) 0.78
Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model. J Biol Chem (2015) 0.77
Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo. J Virol (2016) 0.77
Combinatorial RNA Interference Therapy Prevents Selection of Pre-existing HBV Variants in Human Liver Chimeric Mice. Sci Rep (2015) 0.76
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells. J Hepatol (2016) 0.76
Advances and Challenges in Studying Hepatitis B Virus In Vitro. Viruses (2016) 0.75
Cellular Transplantation for Liver Diseases. Gastroenterology Res (2008) 0.75
Phenotypic changes of human cells in human-rat liver during partial hepatectomy-induced regeneration. World J Gastroenterol (2009) 0.75
A chimeric mouse model to study immunopathogenesis of HCV infection. Methods Mol Biol (2014) 0.75
Cell therapy from bench to bedside: Hepatocytes from fibroblasts - the truth and myth of transdifferentiation. World J Gastroenterol (2015) 0.75
Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection. Virology (2016) 0.75
A novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolism. Nat Commun (2017) 0.75
Human liver chimeric mouse model based on diphtheria toxin-induced liver injury. World J Gastroenterol (2017) 0.75
Humanized mice in translational biomedical research. Nat Rev Immunol (2007) 8.83
Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity (1995) 7.08
Development of a human adaptive immune system in cord blood cell-transplanted mice. Science (2004) 7.07
Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature (2003) 6.92
Hepatitis C virus replication in mice with chimeric human livers. Nat Med (2001) 5.87
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A (1995) 5.06
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol (2007) 5.04
Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet (1996) 4.00
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology (2005) 3.72
Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell (1991) 3.31
Replacement of diseased mouse liver by hepatic cell transplantation. Science (1994) 3.18
Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev (1993) 2.95
Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology (2001) 2.71
Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol (2004) 2.47
Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A (1991) 2.19
"In vivo" depletion of macrophages by liposome-mediated "suicide". Methods Enzymol (2003) 2.17
Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid. Hepatology (1996) 2.05
Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci U S A (1995) 1.65
Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol Ther (2002) 1.46
Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1998) 1.13
A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector. Hepatology (2003) 1.06
Generation of hybrid hepatocytes by cell fusion from monkey embryoid body cells in the injured mouse liver. Histochem Cell Biol (2005) 0.99
NF-kappaB regulation in the immune system. Nat Rev Immunol (2002) 15.80
The knockout mouse project. Nat Genet (2004) 7.80
Production and purification of lentiviral vectors. Nat Protoc (2006) 6.01
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature (2009) 5.37
Gene therapy: therapeutic gene causing lymphoma. Nature (2006) 4.89
Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell (2007) 4.87
A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci U S A (2003) 4.17
Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science (2012) 4.14
Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci U S A (2002) 3.53
Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A (2011) 3.45
A fourth IkappaB protein within the NF-kappaB signaling module. Cell (2007) 3.34
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature (2011) 3.30
Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab (2009) 3.10
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest (2010) 3.10
Development of a novel mouse glioma model using lentiviral vectors. Nat Med (2009) 3.08
Efficient transgenic rat production by a lentiviral vector. Am J Physiol Heart Circ Physiol (2007) 3.07
Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci (2005) 2.75
Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci U S A (2003) 2.71
A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Curr Biol (2010) 2.32
Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature (2005) 2.29
Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci (2003) 2.28
Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy. Blood (2005) 2.12
CtIP links DNA double-strand break sensing to resection. Mol Cell (2009) 2.11
Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J Biol Chem (2002) 2.08
CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc Natl Acad Sci U S A (2004) 1.95
Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol (2005) 1.94
Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model. Nat Cell Biol (2012) 1.87
Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. Nat Cell Biol (2005) 1.75
Microarray and cDNA sequence analysis of transcription during nerve-dependent limb regeneration. BMC Biol (2009) 1.74
Adeno-associated virus effectively mediates conditional gene modification in the brain. Proc Natl Acad Sci U S A (2002) 1.72
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc Natl Acad Sci U S A (2011) 1.68
Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol (2002) 1.66
EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis. Mol Cell (2012) 1.65
Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival. Cancer Cell (2006) 1.62
Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow. Mol Ther (2002) 1.57
Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc Natl Acad Sci U S A (2012) 1.57
Targeted delivery of proteins across the blood-brain barrier. Proc Natl Acad Sci U S A (2007) 1.50
Design and cloning of lentiviral vectors expressing small interfering RNAs. Nat Protoc (2006) 1.48
Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression. Nat Cell Biol (2010) 1.47
Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2014) 1.47
Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science (2004) 1.46
Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP. Proc Natl Acad Sci U S A (2009) 1.45
Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1). Proc Natl Acad Sci U S A (2005) 1.41
Editorial expression of concern: Experimental evidence of massive-scale emotional contagion through social networks. Proc Natl Acad Sci U S A (2014) 1.41
Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation. Cell (2008) 1.41
Reciprocity between phase shifts and amplitude changes in the mammalian circadian clock. Proc Natl Acad Sci U S A (2007) 1.41
IKK biology. Immunol Rev (2012) 1.40
Doping, gene transfer and sport. Mol Ther (2004) 1.39
Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2005) 1.38
Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse. Proc Natl Acad Sci U S A (2005) 1.36
Restoration of spermatogenesis by lentiviral gene transfer: offspring from infertile mice. Proc Natl Acad Sci U S A (2002) 1.35
Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme. J Mol Med (Berl) (2013) 1.31
Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver. Proc Natl Acad Sci U S A (2003) 1.29
Efficient production of human FVIII in hemophilic mice using lentiviral vectors. Mol Ther (2003) 1.29
IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy. Mol Cell Biol (2003) 1.29
Lentiviral short hairpin ribonucleic acid-mediated knockdown of GLUT4 in 3T3-L1 adipocytes. Endocrinology (2006) 1.28
Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am J Pathol (2008) 1.27
Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines. Stem Cells (2011) 1.26
Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Res (2011) 1.25
The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle. Genes Dev (2012) 1.23
A role for IkappaB kinase 2 in bipolar spindle assembly. Proc Natl Acad Sci U S A (2007) 1.21
Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab (2007) 1.21
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy. Mol Ther (2003) 1.20
Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice. BMC Neurosci (2008) 1.20
Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep (2014) 1.16
Applications of lentiviral vectors for shRNA delivery and transgenesis. Curr Gene Ther (2008) 1.14
Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor. Proc Natl Acad Sci U S A (2011) 1.14
Impact, not impact factor. Proc Natl Acad Sci U S A (2015) 1.14
Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics. Proc Natl Acad Sci U S A (2007) 1.10
Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats. Hepatology (2003) 1.10
Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity. Curr Biol (2005) 1.08
Peripheral delivery of a CNS targeted, metalo-protease reduces aβ toxicity in a mouse model of Alzheimer's disease. PLoS One (2011) 1.07
Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors. Blood (2002) 1.07
Bioscience in India: times are changing. Cell (2005) 1.06
Genic regions of a large salamander genome contain long introns and novel genes. BMC Genomics (2009) 1.06
Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther (2002) 1.04
BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription. Proc Natl Acad Sci U S A (2003) 1.03
A structural basis for IκB kinase 2 activation via oligomerization-dependent trans auto-phosphorylation. PLoS Biol (2013) 1.01
Characterization of NF-kappa B/I kappa B proteins in zebra fish and their involvement in notochord development. Mol Cell Biol (2004) 1.01
Rapid generation of knockdown transgenic mice by silencing lentiviral vectors. Nat Protoc (2006) 0.99
Polo-like kinase 4 controls centriole duplication but does not directly regulate cytokinesis. Mol Biol Cell (2012) 0.99
Antiapoptotic protein Lifeguard is required for survival and maintenance of Purkinje and granular cells. Proc Natl Acad Sci U S A (2011) 0.97
PNAS Plus: Refining a successful experiment. Proc Natl Acad Sci U S A (2012) 0.94
Neprilysin protects neurons against Abeta peptide toxicity. Brain Res (2007) 0.93
Inflammatory tales of liver cancer. Cancer Cell (2007) 0.88
Role of BRCA1 in brain development. Proc Natl Acad Sci U S A (2014) 0.87
A role for bone marrow-derived cells in the vasculature of noninjured CNS. Blood (2004) 0.86
Silence of the genes. Proc Natl Acad Sci U S A (2004) 0.84
Targeting expression of the leukemogenic PML-RARα fusion protein by lentiviral vector-mediated small interfering RNA results in leukemic cell differentiation and apoptosis. Hum Gene Ther (2011) 0.83
Development of ecdysone-regulated lentiviral vectors. Mol Ther (2005) 0.82
Sulforaphane inhibits endothelial lipase expression through NF-κB in endothelial cells. Atherosclerosis (2010) 0.82
Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy. Mol Ther (2004) 0.82
Somatic cells with a heavy mitochondrial DNA mutational load render induced pluripotent stem cells with distinct differentiation defects. Stem Cells (2014) 0.81
Organotypic cerebellar cultures: apoptotic challenges and detection. J Vis Exp (2011) 0.80
Design and Cloning of an shRNA into a Lentiviral Silencing Vector: Version A. CSH Protoc (2008) 0.80
SARS: fear of global pandemic. Mol Ther (2003) 0.80
Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo. Endocrinology (2002) 0.79
Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activation. PLoS One (2011) 0.79